help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pleiner, J.
Right arrow Articles by Wolzt, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pleiner, J.
Right arrow Articles by Wolzt, M.
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 6 2913-2917
Copyright © 2002 by The Endocrine Society


Other Original Articles

FFA-Induced Endothelial Dysfunction Can Be Corrected by Vitamin C

Johannes Pleiner, Georg Schaller, Friedrich Mittermayer, Michaela Bayerle-Eder, Michael Roden and Michael Wolzt

Departments of Clinical Pharmacology (J.P., G.S., F.M., M.R., M.W.) and Department of Internal Medicine III, Endocrinology (M.B.-E., M.R.), University of Vienna, Vienna A-1090, Austria

Address all correspondence and requests for reprints to: Dr. Michael Wolzt, Department of Clinical Pharmacology, Allgemeines Krankenhaus Wien, Währinger Gürtel 18-20, A-1090 Vienna, Austria. E-mail: . michael.wolzt{at}univie.ac.at

Abstract

Insulin resistance is associated with an inappropriate elevation of plasma FFA and endothelial dysfunction. FFA could stimulate formation of reactive oxygen species, which could be responsible for vascular impairment. In this randomized, double-blind, cross-over study in 10 healthy volunteers (24 ± 3 yr old), forearm blood flow (FBF) responses to intraarterial acetylcholine (ACh) and glyceryl trinitrate were assessed with coadministration of vitamin C (24 mg/ml) or placebo, respectively, in the presence of increased plasma FFA induced by Intralipid/heparin infusion. The rise in plasma FFA from 320 ± 64 to 1852 ± 232 µmol/liter was associated with a reduced response of FBF to ACh by 55% (P < 0.01). During coadministration of vitamin C, the impaired responsiveness of FBF to ACh was completely reversed and not different from that observed under baseline conditions. Vitamin C did not affect plasma FFA concentrations. Glyceryl trinitrate responsiveness was unchanged during FFA elevation, with or without vitamin C. These data suggest that FFA-induced vascular oxidative stress could contribute to endothelial dysfunction in insulin-resistant patients. High concentrations of antioxidants are able to reverse the local effects of FFA on endothelium-dependent vasodilation.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
F. Mittermayer, G. Schaller, J. Pleiner, K. Krzyzanowska, S. Kapiotis, M. Roden, and M. Wolzt
Rosiglitazone Prevents Free Fatty Acid-Induced Vascular Endothelial Dysfunction
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2574 - 2580.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Watanabe, T. Tagawa, K. Yamakawa, M. Shimabukuro, and S. Ueda
Inhibition of the Renin-Angiotensin System Prevents Free Fatty Acid-Induced Acute Endothelial Dysfunction in Humans
Arterioscler. Thromb. Vasc. Biol., November 1, 2005; 25(11): 2376 - 2380.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Mittermayer, J. Pleiner, G. Schaller, S. Zorn, K. Namiranian, S. Kapiotis, G. Bartel, M. Wolfrum, M. Brugel, J. Thiery, et al.
Tetrahydrobiopterin corrects Escherichia coli endotoxin-induced endothelial dysfunction
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1752 - H1757.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Basi, L. B. Pupim, E. M. Simmons, M. T. Sezer, Y. Shyr, S. Freedman, G. M. Chertow, R. L. Mehta, E. Paganini, J. Himmelfarb, et al.
Insulin resistance in critically ill patients with acute renal failure
Am J Physiol Renal Physiol, August 1, 2005; 289(2): F259 - F264.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Ceriello, R. Assaloni, R. Da Ros, A. Maier, L. Piconi, L. Quagliaro, K. Esposito, and D. Giugliano
Effect of Atorvastatin and Irbesartan, Alone and in Combination, on Postprandial Endothelial Dysfunction, Oxidative Stress, and Inflammation in Type 2 Diabetic Patients
Circulation, May 17, 2005; 111(19): 2518 - 2524.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Ceriello and E. Motz
Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited
Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 816 - 823.
[Abstract] [Full Text]


Home page
J. Leukoc. Biol.Home page
S. K. Andersen, J. Gjedsted, C. Christiansen, and E. Tonnesen
The roles of insulin and hyperglycemia in sepsis pathogenesis
J. Leukoc. Biol., March 1, 2004; 75(3): 413 - 421.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. R. Singleton, A. G. Smith, J. W. Russell, and E. L. Feldman
Microvascular Complications of Impaired Glucose Tolerance
Diabetes, December 1, 2003; 52(12): 2867 - 2873.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Urakawa, A. Katsuki, Y. Sumida, E. C. Gabazza, S. Murashima, K. Morioka, N. Maruyama, N. Kitagawa, T. Tanaka, Y. Hori, et al.
Oxidative Stress Is Associated with Adiposity and Insulin Resistance in Men
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4673 - 4676.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. A. Creager, T. F. Luscher, F. Cosentino, and J. A. Beckman
Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part I
Circulation, September 23, 2003; 108(12): 1527 - 1532.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society